Gain-framed Messages and NRT for Lung Cancer Screening Patients

Status:	Recruiting
Conditions:	Lung Cancer, Smoking Cessation
Therapuetic Areas:	Oncology, Pulmonary / Respiratory Diseases
Healthy:	No
Age Range:	55 - Any
Updated:	8/4/2018
Start Date:	July 1, 2017
End Date:	January 2021
Contact:	Benjamin Toll, PhD
Email:	toll@musc.edu
Phone:	843-876-1132

Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs

This research is a randomized smoking cessation trial conducted within and specifically
personalized for lung cancer screening patients presenting to a lung screening clinic. Novel
tobacco treatments for this population are critically needed, given the growing population of
lung screening patients, which will grow dramatically now that lung screening is an approved
CMS benefit. In the proposed study, we will test a gain-framed messaging intervention
specifically designed for lung screening patients (vs. unframed messaging), as well as
evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be
translational (in that it can be transferable from our controlled efficacy study to other
lung screening programs).

Inclusion Criteria:

1. 55 years or older

2. 30 pack year history of smoking

3. current smoker (defined as any smoking in the past 30 days)

4. willing to be randomized

5. English speaking

Exclusion Criteria:

1. unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis,
severe alcohol dependence, or dementia,

2. known allergy to adhesives

3. being in the immediate (within 2 weeks) post myocardial infarction period

4. serious arrhythmias

5. unstable angina pectoris

6. hemodynamically or electrically unstable.

We found this trial at

sites

Yale Cancer Center

333 Cedar Street
New Haven, Connecticut 06520

(203) 785-4095